½ÃÀ庸°í¼­
»óǰÄÚµå
1610010

ÆèÅ×Å© ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ : À¯Çüº°, ¿ëµµº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2025-2030³â)

FemTech Market Size, Share, & Trends Analysis Report By Type (Devices, Software, Services), By Application (Pregnancy And Nursing Care), By End-use (Direct To Consumer), By Region, And Segment Forecasts, 2025 - 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Grand View Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 150 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

ÆèÅ×Å© ½ÃÀå ¼ºÀå°ú µ¿Çâ:

Grand View Research, Inc.ÀÇ ÃֽŠº¸°í¼­¿¡ µû¸£¸é, ¼¼°è ÆèÅ×Å© ½ÃÀå ±Ô¸ð´Â 2025³âºÎÅÍ 2030³â±îÁö 16.37%ÀÇ CAGRÀ» ±â·ÏÇϸç 2030³â±îÁö 972¾ï 5,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¿©¼º °Ç°­ ¹®Á¦ÀÇ Áõ°¡¿Í °Ç°­ ÀǽÄÀÇ Áõ°¡´Â ½ÃÀåÀÇ ¼ºÀå ÀáÀç·ÂÀ» º¸¿©ÁÖ°í ÀÖ½À´Ï´Ù.

¿©¼º °Ç°­¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö°í ¿©¼º °Ç°­ ¹®Á¦¿¡ ´ëÇÑ Àû±ØÀûÀÎ ´ëó·Î ÀÎÇØ ½ÃÀåÀÌ Å©°Ô ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. µðÁöÅÐ ¹®ÇØ·Â Çâ»ó, °¡Ã³ºÐ ¼Òµæ Áõ°¡, ½º¸¶Æ®Æù°ú ÀÎÅÍ³Ý º¸±Þ, µðÁöÅÐ °Ç°­ ÀÎÇÁ¶ó, ¿©¼º °Ç°­¿¡ ÃÊÁ¡À» ¸ÂÃá ½Å»ý ±â¾÷ÀÇ ÃâÇö µîÀÇ ¿äÀÎÀÌ ½Å±Ô ¹× ±âÁ¸ ½ÃÀå Ç÷¹À̾°Ô À¯¸®ÇÑ ±âȸ¸¦ âÃâÇϰí ÀÖ½À´Ï´Ù. ½º¸¶Æ® ¿þ¾î·¯ºí ±â±âÀÇ °¡¿ë¼ºµµ ½ÃÀå °³Ã´°ú ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. °Ç°­ ±â¼ú °³¹ßÀÚ¿Í ÅõÀÚÀÚµéÀº Áö±Ý±îÁö ¹Ì°³Ã´µÈ ±âȸ¸¦ Ȱ¿ëÇÏ°í ¿©¼º °Ç°­ ¹®Á¦¸¦ ÇØ°áÇϱâ À§ÇÑ Çõ½ÅÀûÀÎ Á¦Ç° °³¹ß Àü·«¿¡ ÀÚ±ÝÀ» Áö¿øÇϰí ÀÖ½À´Ï´Ù.

¶ÇÇÑ, ÁÖ¿ä ½ÃÀå ±â¾÷ÀÇ Àü·«Àû ³ë·ÂÀº ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹¸¦ µé¾î, Ç÷ΠÇコ(Flo Health)´Â 2022³â 6¿ù, Á÷¿øµéÀÇ ¿©¼º °Ç°­¿¡ ÃÊÁ¡À» ¸ÂÃá Á¾ÇÕÀûÀÎ Àü·«ÀÎ Ç÷ΠÆ÷ ºñÁî´Ï½º(Flo for Business)¸¦ Ãâ½ÃÇß½À´Ï´Ù. ÀÌ »õ·Î¿î Á÷¿ø º¹¸®ÈÄ»ý ÇÁ·Î±×·¥Àº °¢ ´Ü°èÀÇ ´Ù¾çÇÑ »ý½Ä °ü·Ã °Ç°­ ¹®Á¦¿¡ ´ëÇÑ °úÇп¡ ±â¹ÝÇÑ Á¾ÇÕÀûÀÎ ÁöħÀ» Á¦°øÇÕ´Ï´Ù. Á÷¿øµéÀÌ »ý¸® ÁÖ±â, »ý½Ä ´É·Â ¹× Àü¹ÝÀûÀÎ »ý½Ä °Ç°­ »óŸ¦ ¸ð´ÏÅ͸µÇÒ ¼ö ÀÖµµ·Ï ±³À°ÇÏ°í ±ÇÇÑÀ» ºÎ¿©ÇÏ´Â ¿©¼º °Ç°­ ¾ÛÀÇ µµÀÔÀº ÀÌ·¯ÇÑ ¾ÛÀÇ Ã¤ÅÃÀ» Áõ°¡½ÃŰ°í ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÆèÅ×Å© ¼Ö·ç¼ÇÀº ¶óÀÌÇÁ½ºÅ¸ÀÏÀ» À¯ÁöÇϰí ÀÚ½ÅÀÇ ¸öÀ» ´õ Àß ÀÌÇØÇϱâ À§ÇØ ÇコÄÉ¾î ¾÷°è¿Í ¿©¼º »ç¿ëÀÚµéÀÌ Å©°Ô ÁÖ¸ñÇϰí ÀÖÀ¸¸ç, 2021³â¿¡ Maternal and Child Health Journal¿¡ °ÔÀçµÈ¿¡ °ÔÀçµÈ Á¶»ç¿¡ µû¸£¸é, ¿©¼º ÀÀ´äÀÚÀÇ ¾à 77.9%°¡ COVID-19 ±â°£ µ¿¾È Àӽаü¸® ¾ÛÀ» »ç¿ëÇß´Ù°í ´äÇß½À´Ï´Ù. ½ÃÀå ±â¾÷µéÀº ½ÃÀå¿¡¼­ °æÀï·ÂÀ» È®´ëÇϱâ À§ÇÑ Àü·«Àû ³ë·Â¿¡ Áö¼ÓÀûÀ¸·Î ÁýÁßÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ Fierce Healthcare¿¡ °ÔÀçµÈ ±â»ç¿¡ µû¸£¸é 2020³â ÆèÅ×Å© »ê¾÷Àº ³ôÀº ÅõÀÚ¸¦ À¯Ä¡Çß½À´Ï´Ù. ¿©¼º¿¡ ÃÊÁ¡À» ¸ÂÃá µðÁöÅÐ Çコ ½ºÅ¸Æ®¾÷Àº 2020³â¿¡ ¾à 105%ÀÇ ÀÚ±Ý Áõ°¡¸¦ ´Þ¼ºÇß½À´Ï´Ù. µû¶ó¼­ COVID-19 ÆÒµ¥¹ÍÀº ½ÃÀå ¼ºÀå¿¡ ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ̸ç, ½ÃÀåÀº ÆÒµ¥¹Í ÀÌÈÄ¿¡µµ »ó½Â¼¼¸¦ º¸ÀÏ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù.

ÆèÅ×Å© ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

  • À¯Çüº°·Î´Â µð¹ÙÀ̽º ºÎ¹®ÀÌ 2024³â 33.33%ÀÇ ¸ÅÃâ Á¡À¯À²·Î ½ÃÀåÀ» Àå¾ÇÇÏ°í ¿¹Ãø ±â°£ µ¿¾È °¡Àå ºü¸¥ ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
  • ¿ëµµº°·Î´Â ÀӽŠ¹× °£º´ ºÐ¾ß°¡ 2024³â 17.72%ÀÇ ¸ÅÃâ Á¡À¯À²·Î ½ÃÀåÀ» Àå¾ÇÇß½À´Ï´Ù.
  • ÃÖÁ¾ ¿ëµµº°·Î´Â ¼ÒºñÀÚ Á÷Á¢ ÆÇ¸Å ºÎ¹®ÀÌ 2024³â 30.82%ÀÇ ¸ÅÃâ Á¡À¯À²·Î ½ÃÀåÀ» Àå¾ÇÇÏ¸ç ¿¹Ãø ±â°£ µ¿¾È °¡Àå ºü¸¥ ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
  • ºÏ¹Ì ÆèÅ×Å© ½ÃÀå Áö¿ªÀº 2024³â 45.90%ÀÇ ÃÖ´ë ¸ÅÃâ Á¡À¯À²·Î ½ÃÀåÀ» Àå¾ÇÇß½À´Ï´Ù. ÆèÅ×Å© Á¦Ç°¿¡¼­ AI¿Í °°Àº ±â¼ú ¹ßÀüÀÇ È®´ë´Â ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
  • Ç÷Î(Flo)´Â °¡Àå ¸¹ÀÌ ´Ù¿î·Îµå/°¡ÀÔµÈ ¾ÛÀ¸·Î 2021³â±îÁö 2¾ï ´Ù¿î·Îµå¸¦ µ¹ÆÄÇß½À´Ï´Ù. ÀÌ ¾ÛÀº ÁÖ·Î »ý¸® ¹× °¡ÀÓ·Â ÃßÀû¿¡ ´ëÀÀÇϰí ÀÖ½À´Ï´Ù.
  • Natural Cycles¿Í Clue´Â FDA°¡ ½ÂÀÎÇÑ µðÁöÅÐ ÇÇÀÓ ¾ÛÀ¸·Î, º£ÀÌÁö¾È ¸ðµ¨¸µÀ» »ç¿ëÇÏ¿© °¡Àå ÀÓ½ÅÇϱ⠽¬¿î ³¯(°íÀ§Ç豺)À» ¿¹ÃøÇÏ´Â ¾ÛÀÔ´Ï´Ù.
  • 2023³â 2¿ù, ÅØ»ç½ºÀÇ ¿©¼º °Ç°­ ½ºÅ¸Æ®¾÷ÀÌ ChatGPT¿¡¼­ ¿µ°¨À» ¹ÞÀº AI ±â¹Ý äÆÃ ¾ÛÀÎ Ema app(ÀÌÀü¿¡´Â SocialMama¶ó°í ºÒ·ÈÀ½)À» Ãâ½ÃÇß½À´Ï´Ù. ÀÌ·¯ÇÑ ¹ßÀüÀº ÆèÅ×Å© ¾ÛÀÇ Ã¤ÅÃÀ» È®´ëÇϰí ÀÌ Áö¿ªÀÇ ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÏ´Â µ¥ µµ¿òÀÌ µÉ °ÍÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå º¯¼ö, µ¿Çâ, ¹üÀ§

  • ½ÃÀå °èÅë Àü¸Á
  • ½ÃÀå ¿ªÇÐ
    • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ºÐ¼®
    • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ ºÐ¼®
  • ºñÁî´Ï½º ȯ°æ ºÐ¼®
    • ¾÷°è ºÐ¼® - Porter's Five Forces ºÐ¼®
    • PESTLE ºÐ¼®

Á¦4Àå À¯Çü ºñÁî´Ï½º ºÐ¼®

  • À¯Çü ½ÃÀå Á¡À¯À², 2024³â¡¤2030³â
  • À¯Çü ºÎ¹® ´ë½Ãº¸µå
  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø°ú µ¿Ç⠺м®, À¯Çüº°, 2018-2030³â
  • µð¹ÙÀ̽º
    • µð¹ÙÀ̽º ½ÃÀå ÃßÁ¤°ú ¿¹Ãø, 2018-2030³â
  • ¼ÒÇÁÆ®¿þ¾î
    • ¼ÒÇÁÆ®¿þ¾î ½ÃÀå ÃßÁ¤°ú ¿¹Ãø, 2018-2030³â
  • ¼­ºñ½º
    • ¼­ºñ½º ½ÃÀå ÃßÁ¤°ú ¿¹Ãø, 2018-2030³â
  • ¼ÒºñÀç
    • ¼ÒºñÀÚ Á¦Ç° ½ÃÀå ÃßÁ¤°ú ¿¹Ãø, 2018-2030³â

Á¦5Àå ¿ëµµ ºñÁî´Ï½º ºÐ¼®

  • ¿ëµµ ½ÃÀå Á¡À¯À², 2024³â¡¤2030³â
  • ¿ëµµ ºÎ¹® ´ë½Ãº¸µå
  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø°ú µ¿Ç⠺м®, ¿ëµµº°, 2018-2030³â
  • Àӽš¤°£È£ Äɾî
    • Àӽš¤°£È£ ÄÉ¾î ½ÃÀå ÃßÁ¤°ú ¿¹Ãø, 2018-2030³â
  • »ý½Ä º¸°Ç¡¤ÇÇÀÓ
    • »ý½Ä º¸°Ç¡¤ÇÇÀÓ ½ÃÀå ÃßÁ¤°ú ¿¹Ãø, 2018-2030³â
  • ¿ù°æ °Ç°­
    • ¿ù°æ °Ç°­ ½ÃÀå ÃßÁ¤°ú ¿¹Ãø, 2018-2030³â
  • ÀϹÝÀûÀÎ °Ç°­
    • ÀϹÝÀûÀÎ °Ç°­ ½ÃÀå ÃßÁ¤°ú ¿¹Ãø, 2018-2030³â
  • °ñ¹Ý¡¤Àڱà °Ç°­
    • °ñ¹Ý¡¤Àڱà °Ç°­ ½ÃÀå ÃßÁ¤°ú ¿¹Ãø, 2018-2030³â
  • ¼ºÀû °Ç°­
    • ¼º °Ç°­ ½ÃÀå ÃßÁ¤°ú ¿¹Ãø, 2018-2030³â
  • ¿©¼º °Ç°­
    • ¿©¼º °Ç°­ ½ÃÀå ÃßÁ¤°ú ¿¹Ãø, 2018-2030³â
  • °»³â±â Äɾî
    • °»³â±â ÄÉ¾î ½ÃÀå ÃßÁ¤°ú ¿¹Ãø, 2018-2030³â
  • Àå¼ö¡¤Á¤½Å°Ç°­
    • Àå¼ö¡¤Á¤½Å°Ç°­ ½ÃÀå ÃßÁ¤°ú ¿¹Ãø, 2018-2030³â

Á¦6Àå ÃÖÁ¾ ¿ëµµ ºñÁî´Ï½º ºÐ¼®

  • ÃÖÁ¾ ¿ëµµ ½ÃÀå Á¡À¯À², 2024³â¡¤2030³â
  • ÃÖÁ¾ ¿ëµµ ºÎ¹® ´ë½Ãº¸µå
  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø°ú µ¿Ç⠺м®, ÃÖÁ¾ ¿ëµµº°, 2018-2030³â
  • ¼ÒºñÀÚ¿ë Á÷Á¢ ÆÇ¸Å
    • ¼ÒºñÀÚ¿ë Á÷Á¢ ÆÇ¸Å ½ÃÀå ÃßÁ¤°ú ¿¹Ãø, 2018-2030³â
  • º´¿ø
    • º´¿ø ½ÃÀå ÃßÁ¤°ú ¿¹Ãø, 2018-2030³â
  • ¿Ü°ú ¼¾ÅÍ
    • ¿Ü°ú ¼¾ÅÍ ½ÃÀå ÃßÁ¤°ú ¿¹Ãø, 2018-2030³â
  • ºÒÀÓ Ä¡·á Ŭ¸®´Ð
    • ºÒÀÓ Ä¡·á Ŭ¸®´Ð ½ÃÀå ÃßÁ¤°ú ¿¹Ãø, 2018-2030³â
  • Áø´Ü ¼¾ÅÍ
    • Áø´Ü ¼¾ÅÍ ½ÃÀå ÃßÁ¤°ú ¿¹Ãø, 2018-2030³â
  • ±âŸ
    • ±âŸ ½ÃÀå ÃßÁ¤°ú ¿¹Ãø, 2018-2030³â

Á¦7Àå Áö¿ª ÃßÁ¤¡¤µ¿Ç⠺м® : À¯Çüº°, ¿ëµµº°, ÃÖÁ¾ ¿ëµµº°

  • Áö¿ªº° ½ÃÀå Á¡À¯À² ºÐ¼®, 2024³â¡¤2030³â
  • Áö¿ª ½ÃÀå ´ë½Ãº¸µå
  • ½ÃÀå ±Ô¸ð, ¿¹Ãø µ¿Ç⠺м®, 2018-2030³â :
  • ºÏ¹Ì
    • ºÏ¹ÌÀÇ ÆèÅ×Å© ½ÃÀå ÃßÁ¤°ú ¿¹Ãø, 2018-2030³â
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • À¯·´ÀÇ ÆèÅ×Å© ½ÃÀå ÃßÁ¤°ú ¿¹Ãø, 2018-2030³â
    • µ¶ÀÏ
    • ¿µ±¹
    • ÇÁ¶û½º
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • µ§¸¶Å©
    • ½º¿þµ§
    • ³ë¸£¿þÀÌ
    • ·¯½Ã¾Æ
    • ¾ÆÀ̽½¶õµå
    • Çɶõµå
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÆèÅ×Å© ½ÃÀå ÃßÁ¤°ú ¿¹Ãø, 2018-2030³â
    • ÀϺ»
    • Áß±¹
    • Àεµ
    • Çѱ¹
    • È£ÁÖ
    • ű¹
    • ½Ì°¡Æ÷¸£
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ¶óƾ¾Æ¸Þ¸®Ä«ÀÇ ÆèÅ×Å© ½ÃÀå ÃßÁ¤°ú ¿¹Ãø, 2018-2030³â
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« ÆèÅ×Å© ½ÃÀå ÃßÁ¤°ú ¿¹Ãø, 2018-2030³â
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®
    • Äí¿þÀÌÆ®
    • À̽º¶ó¿¤

Á¦8Àå °æÀï ±¸µµ

  • Âü¿©ÀÚ °³¿ä
  • ±â¾÷ÀÇ ½ÃÀå Æ÷Áö¼Ç ºÐ¼®
  • ±â¾÷ ºÐ·ù
  • Àü·« ¸ÅÇÎ
  • ±â¾÷ °³¿ä/¸®½ºÆ®
    • Chiaro Technology Limited
    • HeraMED
    • Flo Health, Inc.
    • Natural Cycles USA Corp
    • Glow, Inc
    • Allara Health
    • NUVO Inc.
    • Bloomlife
    • Syrona Health
    • Sirona Hygiene Private Limited
    • Samplytics Technologies Private Limited
    • iSono Health, Inc.
    • Athena Feminine Technologies
ksm 24.12.27

FemTech Market Growth & Trends:

The global FemTech market size is expected to reach USD 97.25 billion by 2030, registering a CAGR of 16.37% from 2025 to 2030, according to a new report by Grand View Research, Inc. Rising number of women's health issues and growing health consciousness indicates the growth potential of the market.

The increasing awareness about health among women and the proactive approach to addressing women's health issues will lead to significant market growth. Factors such as rising digital literacy, disposable income, widespread smartphone and internet use, digital health infrastructure, and the emergence of startups focusing on women's health are creating lucrative opportunities for both new and existing market players. The availability of smart wearable devices is also contributing to market development and growth. Health technology developers and investors are taking advantage of previously untapped opportunities and funding innovative product development strategies to address women's health issues.

Furthermore, the strategic initiatives by the major market players are anticipated to increase market growth during the forecast period. For instance, in June 2022, Flo Health launched Flo for Business, an inclusive strategy focused on women's health for employees. This new employee benefit provides comprehensive, science-based guidance on various reproductive health issues at every stage of life. The introduction of women's health apps aimed at educating and empowering employees to monitor their menstrual cycles, fertility, and overall reproductive health is expected to increase the adoption of such apps, thereby boosting the growth of the market.

FemTech solutions received significant exposure and witnessed a dramatic adoption rate by the healthcare fraternity and female users in maintaining lifestyles and understanding their bodies better. According to a study published in the Maternal and Child Health Journal in 2021, it stated approximately 77.9% of female respondents were using pregnancy care management apps during the pandemic. Market players are constantly focusing on their strategic initiatives to expand their competitive edge in the market. In addition, as per an article published in Fierce Healthcare, the FemTech industry attracted high investments in 2020. The digital health startups focused on women witnessed an increase in funding by around 105% in 2020. Hence, the COVID-19 pandemic impacted the market growth, and the market is estimated to witness an upward trend in the post-pandemic period.

FemTech Market Report Highlights:

  • In terms of type, the devices segment dominated the market with a revenue share of 33.33% in 2024 and expected to have the fastest growth rate during the forecast period.
  • Based on the application the pregnancy and nursing care segment dominated the market in 2024 with a revenue share of 17.72%.
  • Based on the end-use, the direct-to-consumer segment dominated the market with a revenue share of 30.82% in 2024 and expected to have the fastest growth rate during the forecast period.
  • North America FemTech market region dominated the market with largest revenue share of 45.90% in 2024. The growing technological advancements, such as AI in FemTech products are expected to drive market growth over the forecast period.
  • Flo is the most downloaded/subscribed app, with over 200 million downloads by 2021. This app majorly caters to period & fertility tracking
  • Natural Cycles ad Clue are a few FDA approved digital contraceptive apps that use Bayesian modeling for the prediction of the most fertile days (The high-risk window)
  • In February 2023, an AI-based chat application Ema app, previously called SocialMama inspired by ChatGPT has been released by a women's health start-up in Texas. Such advancements help in the increased adoption of FemTech apps, driving market growth in the region

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Application
    • 1.2.3. End Use
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Volume Price Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rise in adoption of digital health solution
      • 3.2.1.2. Advancement in artificial intelligence and virtual assistance
      • 3.2.1.3. Growth in investments and funding in FemTech industry
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Lack of awareness about FemTech products and applications in developing nations
      • 3.2.2.2. Cybersecurity and privacy concerns
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Type Business Analysis

  • 4.1. Type Market Share, 2024 & 2030
  • 4.2. Type Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 4.4. Devices
    • 4.4.1. Devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.5. Software
    • 4.5.1. Software market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.6. Services
    • 4.6.1. Services market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.7. Consumer Products
    • 4.7.1. Consumer products market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 5. Application Business Analysis

  • 5.1. Application Market Share, 2024 & 2030
  • 5.2. Application Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analyses, by Application, 2018 to 2030 (USD Million)
  • 5.4. Pregnancy and Nursing Care
    • 5.4.1. Pregnancy and nursing care market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.5. Reproductive Health & Contraception
    • 5.5.1. Reproductive health & contraception market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.6. Menstrual Health
    • 5.6.1. Menstrual health market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.7. General Health
    • 5.7.1. General health market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.8. Pelvic & Uterine Health
    • 5.8.1. Pelvic & uterine health market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.9. Sexual Health
    • 5.9.1. Sexual health market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.10. Women's Wellness
    • 5.10.1. Women's wellness market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.11. Menopause Care
    • 5.11.1. Menopause care market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.12. Longevity & Mental Health
    • 5.12.1. Longevity & mental health market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 6. End Use Business Analysis

  • 6.1. End Use Market Share, 2024 & 2030
  • 6.2. End Use Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analyses, by End Use, 2018 to 2030 (USD Million)
  • 6.4. Direct To Consumer
    • 6.4.1. Direct to consumer market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.5. Hospitals
    • 6.5.1. Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.6. Surgical Centers
    • 6.6.1. Surgical centers market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.7. Fertility Clinics
    • 6.7.1. Fertility Clinics market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.8. Diagnostic Centers
    • 6.8.1. Diagnostic Centers market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.9. Others
    • 6.9.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 7. Regional Estimates & Trend Analysis by Type, Application & End Use

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.4. North America
    • 7.4.1. North America FemTech market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key country dynamic
      • 7.4.2.2. Regulatory framework
      • 7.4.2.3. Competitive insights
      • 7.4.2.4. U.S. FemTech market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key country dynamic
      • 7.4.3.2. Regulatory framework
      • 7.4.3.3. Competitive insights
      • 7.4.3.4. Canada FemTech market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key country dynamic
      • 7.4.4.2. Regulatory framework
      • 7.4.4.3. Competitive insights
      • 7.4.4.4. Mexico FemTech market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe FemTech market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. Germany
      • 7.5.2.1. Key country dynamic
      • 7.5.2.2. Regulatory framework
      • 7.5.2.3. Competitive insights
      • 7.5.2.4. Germany FemTech market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. UK
      • 7.5.3.1. Key country dynamic
      • 7.5.3.2. Regulatory framework
      • 7.5.3.3. Competitive insights
      • 7.5.3.4. UK FemTech market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key country dynamic
      • 7.5.4.2. Regulatory framework
      • 7.5.4.3. Competitive insights
      • 7.5.4.4. France FemTech market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key country dynamic
      • 7.5.5.2. Regulatory framework
      • 7.5.5.3. Competitive insights
      • 7.5.5.4. Italy FemTech market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key country dynamic
      • 7.5.6.2. Regulatory framework
      • 7.5.6.3. Competitive insights
      • 7.5.6.4. Spain FemTech market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.7. Denmark
      • 7.5.7.1. Key country dynamic
      • 7.5.7.2. Regulatory framework
      • 7.5.7.3. Competitive insights
      • 7.5.7.4. Denmark FemTech market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.8. Sweden
      • 7.5.8.1. Key country dynamic
      • 7.5.8.2. Regulatory framework
      • 7.5.8.3. Competitive insights
      • 7.5.8.4. Sweden FemTech market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.9. Norway
      • 7.5.9.1. Key country dynamic
      • 7.5.9.2. Regulatory framework
      • 7.5.9.3. Competitive insights
      • 7.5.9.4. Norway FemTech market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.10. Russia
      • 7.5.10.1. Key country dynamic
      • 7.5.10.2. Regulatory framework
      • 7.5.10.3. Competitive insights
      • 7.5.10.4. Norway FemTech market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.11. Iceland
      • 7.5.11.1. Key country dynamic
      • 7.5.11.2. Regulatory framework
      • 7.5.11.3. Competitive insights
      • 7.5.11.4. Norway FemTech market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.12. Finland
      • 7.5.12.1. Key country dynamic
      • 7.5.12.2. Regulatory framework
      • 7.5.12.3. Competitive insights
      • 7.5.12.4. Norway FemTech market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific FemTech market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key country dynamic
      • 7.6.2.2. Regulatory framework
      • 7.6.2.3. Competitive insights
      • 7.6.2.4. Japan FemTech market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key country dynamic
      • 7.6.3.2. Regulatory framework
      • 7.6.3.3. Competitive insights
      • 7.6.3.4. China FemTech market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key country dynamic
      • 7.6.4.2. Regulatory framework
      • 7.6.4.3. Competitive insights
      • 7.6.4.4. India FemTech market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. South Korea
      • 7.6.5.1. Key country dynamic
      • 7.6.5.2. Regulatory framework
      • 7.6.5.3. Competitive insights
      • 7.6.5.4. South Korea FemTech market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.6. Australia
      • 7.6.6.1. Key country dynamic
      • 7.6.6.2. Regulatory framework
      • 7.6.6.3. Competitive insights
      • 7.6.6.4. Australia FemTech market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key country dynamic
      • 7.6.7.2. Regulatory framework
      • 7.6.7.3. Competitive insights
      • 7.6.7.4. Thailand FemTech market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.8. Singapore
      • 7.6.8.1. Key country dynamic
      • 7.6.8.2. Regulatory framework
      • 7.6.8.3. Competitive insights
      • 7.6.8.4. Thailand FemTech market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America FemTech market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key country dynamic
      • 7.7.2.2. Regulatory framework
      • 7.7.2.3. Competitive insights
      • 7.7.2.4. Brazil FemTech market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key country dynamic
      • 7.7.3.2. Regulatory framework
      • 7.7.3.3. Competitive insights
      • 7.7.3.4. Argentina FemTech market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.8. MEA
    • 7.8.1. MEA FemTech market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key country dynamic
      • 7.8.2.2. Regulatory framework
      • 7.8.2.3. Competitive insights
      • 7.8.2.4. South Africa FemTech market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key country dynamic
      • 7.8.3.2. Regulatory framework
      • 7.8.3.3. Competitive insights
      • 7.8.3.4. Saudi Arabia FemTech market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key country dynamic
      • 7.8.4.2. Regulatory framework
      • 7.8.4.3. Competitive insights
      • 7.8.4.4. UAE FemTech market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key country dynamic
      • 7.8.5.2. Regulatory framework
      • 7.8.5.3. Competitive insights
      • 7.8.5.4. Kuwait FemTech market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.8.6. Israel
      • 7.8.6.1. Key country dynamic
      • 7.8.6.2. Regulatory framework
      • 7.8.6.3. Competitive insights
      • 7.8.6.4. Kuwait FemTech market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Overview
  • 8.2. Company Market Position Analysis
  • 8.3. Company Categorization
  • 8.4. Strategy Mapping
  • 8.5. Company Profiles/Listing
    • 8.5.1. Chiaro Technology Limited
      • 8.5.1.1. Overview
      • 8.5.1.2. Financial performance
      • 8.5.1.3. Product and Service benchmarking
      • 8.5.1.4. Strategic initiatives
    • 8.5.2. HeraMED
      • 8.5.2.1. Overview
      • 8.5.2.2. Financial performance
      • 8.5.2.3. Product and Service benchmarking
      • 8.5.2.4. Strategic initiatives
    • 8.5.3. Flo Health, Inc.
      • 8.5.3.1. Overview
      • 8.5.3.2. Financial performance
      • 8.5.3.3. Product and Service benchmarking
      • 8.5.3.4. Strategic initiatives
    • 8.5.4. Natural Cycles USA Corp
      • 8.5.4.1. Overview
      • 8.5.4.2. Financial performance
      • 8.5.4.3. Product and Service benchmarking
      • 8.5.4.4. Strategic initiatives
    • 8.5.5. Glow, Inc
      • 8.5.5.1. Overview
      • 8.5.5.2. Financial performance
      • 8.5.5.3. Product and Service benchmarking
      • 8.5.5.4. Strategic initiatives
    • 8.5.6. Allara Health
      • 8.5.6.1. Overview
      • 8.5.6.2. Financial performance
      • 8.5.6.3. Product and Service benchmarking
      • 8.5.6.4. Strategic initiatives
    • 8.5.7. NUVO Inc.
      • 8.5.7.1. Overview
      • 8.5.7.2. Financial performance
      • 8.5.7.3. Product and Service benchmarking
      • 8.5.7.4. Strategic initiatives
    • 8.5.8. Bloomlife
      • 8.5.8.1. Overview
      • 8.5.8.2. Financial performance
      • 8.5.8.3. Product and Service benchmarking
      • 8.5.8.4. Strategic initiatives
    • 8.5.9. Syrona Health
      • 8.5.9.1. Overview
      • 8.5.9.2. Financial performance
      • 8.5.9.3. Product and Service benchmarking
      • 8.5.9.4. Strategic initiatives
    • 8.5.10. Sirona Hygiene Private Limited
      • 8.5.10.1. Overview
      • 8.5.10.2. Financial performance
      • 8.5.10.3. Product and Service benchmarking
      • 8.5.10.4. Strategic initiatives
    • 8.5.11. Samplytics Technologies Private Limited
      • 8.5.11.1. Overview
      • 8.5.11.2. Financial performance
      • 8.5.11.3. Product and Service benchmarking
      • 8.5.11.4. Strategic initiatives
    • 8.5.12. iSono Health, Inc.
      • 8.5.12.1. Overview
      • 8.5.12.2. Financial performance
      • 8.5.12.3. Product and Service benchmarking
      • 8.5.12.4. Strategic initiatives
    • 8.5.13. Athena Feminine Technologies
      • 8.5.13.1. Overview
      • 8.5.13.2. Financial performance
      • 8.5.13.3. Product and Service benchmarking
      • 8.5.13.4. Strategic initiatives
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦